Impact of sFRP1 Overexpression on Bone Formation and PTH Effects
Author Information
Author(s): Yao Wei, Cheng Zhiqiang, Shahnazari Mohammad, Dai Wewei, Johnson Mark L, Lane Nancy E
Primary Institution: UC Davis Medical Center
Hypothesis
Overexpression of sFRP1 in sFRP1 transgenic mice would reduce osteoblast number and activity, leading to lower peak bone mass and reduced bone acquisition.
Conclusion
Overexpression of sFRP1 inhibits bone formation and attenuates the anabolic effects of parathyroid hormone on bone.
Supporting Evidence
- Trabecular bone mass was significantly lower in sFRP1 Tg mice compared to wild-type controls.
- Bone formation markers decreased significantly in sFRP1 Tg mice.
- PTH treatment increased bone volume in wild-type mice but had minimal effects in sFRP1 Tg mice.
- Surface-based bone formation decreased by 68% in female and 48% in male sFRP1 Tg mice compared to controls.
- Active β-catenin levels were significantly lower in sFRP1 Tg mice.
Takeaway
Mice with too much sFRP1 have weaker bones and don't grow as strong when given a hormone that usually helps bones grow.
Methodology
The study involved evaluating skeletal phenotype, measuring bone mass and microarchitecture using micro-computed tomography, and assessing osteoblastic and osteoclastic cell maturation in primary bone marrow cell cultures.
Limitations
The study only evaluated 12- to 14-week-old animals and did not assess age-related changes or the effects of longer PTH treatment.
Participant Demographics
The study involved both male and female mice.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website